Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2008
10/29/2008CN101293094A Recombined staphylococcus aureus enterotoxin K oral preparation and application thereof
10/29/2008CN101293093A Recombined staphylococcus aureus enterotoxin M oral preparation and application thereof
10/29/2008CN101293092A Recombined staphylococcus aureus enterotoxin I oral preparation and application thereof
10/29/2008CN101293089A Method for preparing phaescolosaxin oral administration dosage form
10/29/2008CN101293073A Chinese medicinal composition for treating systematic lupus erythematosus
10/29/2008CN101293070A Extraction of seal wort oligose with effect of reinforcing immune function from seal wort
10/29/2008CN101293036A Compound essential oil for treating common cold, allergic rhinitis and pharyngitis, and preparation method thereof
10/29/2008CN101292742A Health food for reinforcing immune function of human body and preparation technique thereof
10/29/2008CN101292689A Functional liver-protecting sobering up tea
10/29/2008CN101292688A Method for preparing folium phyllostachytis green tea effervescence piece
10/29/2008CN100429233C Recombinant solvent protein, its production and use
10/29/2008CN100429232C Vaughan Tristan J.
10/29/2008CN100428966C Nasal delivery devices
10/29/2008CN100428959C Process for producing drug ultramicroparticle and apparatus therefor
10/29/2008CN100428893C Health-care food contg. giant salamander, and its production method
10/28/2008US7442807 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
10/28/2008US7442790 Caspase inhibitors and uses thereof
10/28/2008US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics
10/28/2008US7442703 Piperidine derivatives useful as CCR5 antagonists
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442698 Substituted heterocyclic compounds and methods of use
10/28/2008US7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
10/28/2008US7442547 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
10/28/2008US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/28/2008CA2472107C Dibenzodiazepine derivates, their preparation and use
10/28/2008CA2442227C Ccr5 antagonists useful for treating aids
10/28/2008CA2417652C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2358632C Drug combinations comprising (e)-7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino|pyrimidin-5-yl|(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
10/28/2008CA2300876C Naphthoquinone derivatives as hiv matrix protein tyrosine position 29 pocket binders
10/28/2008CA2225924C Recombinant mistletoe lectin
10/28/2008CA2170748C Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
10/23/2008WO2008128045A1 Solid forms of (e) -1- (4- ( (1r, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl)ethanone oxime
10/23/2008WO2008127975A2 Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008WO2008126940A1 Novel t cell
10/23/2008WO2008126905A1 Evaluation method and screening method for substance having action of activating/suppressing innate immunity, agent and food product for activating/suppressing innate immune mechanism and method for producing the same
10/23/2008WO2008126886A1 Indole or indoline derivative
10/23/2008WO2008126752A1 Skin-lightening agent containing equol compound as active ingredient
10/23/2008WO2008126638A1 Anti-histamine substance and method for production thereof
10/23/2008WO2008125412A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
10/23/2008WO2008125366A2 Treatment of autoimmune diseases
10/23/2008WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof
10/23/2008US20080262210 Immunostimulating Agents
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
10/23/2008US20080262080 Allergy Suppressive Agent
10/23/2008US20080262079 Cannabinoid Compositions and Methods of Use Thereof
10/23/2008US20080262068 Method of Tonic Treatment With Oxyphenbutazone Derivatives
10/23/2008US20080262065 Novel inhibitors of glutaminyl cyclases
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262035 Amide Derivatives as Inhibitors of Histone Deacetylase
10/23/2008US20080262018 Treating allergic and inflammatory conditions
10/23/2008US20080262017 human ingestion, that are sugar free, clear in color; loratadine, desloratadine, or a pharmaceutically acceptable salt
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261981 3-{4-[4-(2-amino-3-morpholin-4-yl-3-oxo-propyl)-phenoxy]-phenyl}-N-hydroxypropionamide hydrochloride; for reducing blood glucose, free fatty acids, cholesterol, triglycerides levels
10/23/2008US20080261977 Pyrimidine Derivatives as Cannabinoid Receptor Modulators
10/23/2008US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
10/23/2008US20080261966 Bis-aryl sulfonamides
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261943 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261869 For treating bacterial and viral infections; kits
10/23/2008US20080261271 Expression of hiv polypeptides and production of virus-like particles
10/23/2008US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
10/23/2008US20080260829 Bone morphogenic proteins (bmp); cell adhesion modulating agent; peptidomimetics of cyclic peptides comprising classical cadherin cell adhesion recognition (CAR) sequences; modulate cell adhesion and improve drug delivery
10/23/2008US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification
10/23/2008US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta)
10/23/2008US20080260783 Composition and method for controlling intestinal pathogenic organisms
10/23/2008US20080260782 Mycobacterium avium subspecies paratuberculosis vaccines and methods of using the same
10/23/2008US20080260781 Proteosome influenza vaccine
10/23/2008US20080260778 Bovine viral diarrhea virus; veterinary medicine
10/23/2008US20080260776 Preparation of Salmonella Broad-Spectrum Vaccines
10/23/2008US20080260775 Modified Rna virus packaged with structural proteins and second virus; induce immunology response
10/23/2008US20080260774 Activation cytokine response in immune system including lymphocyte and antigen; anticancer agents; infection diseases; autoimmune disease; vaccine
10/23/2008US20080260773 Carrier protein containing t cell epitopes from pathogens conjugated to saccharide antigens
10/23/2008US20080260770 Use of Tellurium Compounds as Adjuvants
10/23/2008US20080260767 Novel Protein Which can be Used, in Particular, for the In Vitro Isolation and Prevention of Legionella Pneumophila Infections
10/23/2008US20080260765 Nucleotide sequences coding human papilloma viral early and late gene for use in developing vaccine for prevention and treatment of cervical cell proliferative disorders
10/23/2008US20080260759 Novel Mite Allergen
10/23/2008US20080260758 Cell which expresses granulocyte colony stimulating factor and is deficient in major histocompatibility class I (MHC-I) antigens and major histocompatibility class II (MHC-II) antigens and which stimulates immune response to cancer
10/23/2008US20080260754 Prevent transplant rejection; autoimmune diseases
10/23/2008US20080260751 Using activator of toll like receptor-4 protein as therapeutic in treatment and prevention of arthritic, inflammatory, kidney, skin bone, respiratory, brain, cell proliferative and liver disorders
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260737 Using B Lymphocyte stimulator (BLyS) a ntagonist to decrease immunoglobulin levels in mammals; treating diabetes, multiple sclerosis and/or inflammatory bowel diseases
10/23/2008US20080260731 Fc gamma RIIIa receptor specific immunoglobulin comprising reduced fucose mdoification for use in treatment and prevention of cell proliferative and autoimmune diseases
10/23/2008US20080260730 Using cytokine specific immunoglobulin for treatment and prevention of inflammatory, skin and autoimmune disorders
10/23/2008US20080260727 Modulation of Nkg2d
10/23/2008US20080260719 EDG: Modulators of lymphocyte activation and migration
10/23/2008US20080260690 Viricidal protein for use in prevention and treatment of respiratory system infection
10/23/2008US20080260689 Mixture comprising Interleukin receptor amino acid sequences for use in developing vaccine for prevention and treatment of autoimmune diseases; genetic vaccines
10/23/2008US20080260688 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/23/2008US20080260687 Identifying modulators which interfere with interleukin-6 and interleukin-6 receptor binding; antitumor agents; treating cell proliferative disorders
10/23/2008US20080260680 Method of Attenuating Reactions to Skin Irritants
10/23/2008CA2688693A1 Interferons of rhesus and cynomolgus origin and uses thereof
10/23/2008CA2683963A1 Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime
10/23/2008CA2682730A1 Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008CA2681596A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1983000A2 Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
10/22/2008EP1982992A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 1172